SINOTHERAPEUTICS: The company's products are expected to be selected for the national centralized procurement of drugs
SINOTHERAPEUTICS announced that the company recently participated in the bidding organized by the National Organization for Drug Procurement Office for the 11th batch of national centralized drug procurement. According to the "Public Announcement of Proposed Selected Results for National Centralized Drug Procurement" released by the procurement office on October 28, 2025, the company's product Olaparib tablets is proposed to be selected for this centralized procurement
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments